제약 중간체 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00005559
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 185
Buy Now

의약 중간체 시장은 2020년 273억 5670만 달러에서 2028년 372억 9033만 달러에 이를 것으로 예상됩니다. 이 시장은 2021-2028년까지 연평균 4.2% 성장할 것으로 예상됩니다.



제약 중간체 시장은 유형, 응용 프로그램, 유통 채널 및 지역을 기준으로 분석되었습니다. 지역 기반 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다. 이 보고서는 시장 동향, 기술 발전, 시장 역학 및 주요 회사의 경쟁 구도 분석과 같은 매개 변수를 강조하여 제약 중간체 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 모든 주요 지역의 시장 전반에 걸친 COVID-19 대유행 분석도 포함됩니다.



제약 중간체 시장의 수익성 있는 지역



시장 통찰력



만성 질환 및 전염병의 유병률 증가



< p>의약 중간체는 활성 제약 성분(API)의 빌딩 블록입니다. 이들은 대량 의약품 생산 중에 분자 변화 또는 가공을 겪는 원료입니다. 따라서, 만성 질환을 치료하기 위한 약물에 대한 수요가 증가함에 따라 의약품 중간체의 요구 사항이 증가합니다. 질병 통제 예방 센터(CDC)에 따르면 미국 성인 10명 중 6명은 암, 심장병, 폐 질환, 뇌졸중, 신경계 질환, 당뇨병, 신장 질환과 같은 적어도 하나의 만성 질환을 앓고 있습니다. 더욱이 우리나라 성인 10명 중 4명은 2개 이상의 만성질환을 가지고 있다. 또한 유럽만성질환연맹(ECDA)의 보도자료에 따르면 2014년 유럽인 10명 중 9명이 만성질환으로 사망한다. 따라서 전체 의료비의 70~80%가 만성질환 관리에 사용된다.



특히 동남아시아에서 급증하는 전염병 유행은 또한 향후 API 수요를 촉진하여 결국 의약품 중간체 시장의 성장을 주도할 가능성이 있습니다. 예를 들어 개정된 국가 결핵 통제 프로그램 보고서에 따르면 2018년 인도에서 약 440만 명의 환자가 결핵으로 사망했으며, 이는 전 세계 결핵으로 인한 총 150만 명의 사망 중 29%에 해당합니다. 따라서 만성 질환 및 전염병의 높은 유병률은 의약품에 대한 수요를 강화하고 있으며 결국 의약품 중간체의 필요성을 강조하고 있습니다.



유형 기반 통찰력



의약 중간체 시장은 종류에 따라 GMP와 Non GMP로 구분됩니다. GMP 부문은 2020년에 시장에서 가장 큰 점유율을 차지한 반면, 동일한 부문은 예측 기간 동안 시장에서 4.4%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.




의약 중간체 시장, 유형별 - 2020년 및 2028년



응용 기반 통찰력



의약품 중간체 시장은 응용 분야별로 항생제, 해열 진통제, 비타민, 기타. 항생제 부문은 2020년에 시장에서 가장 큰 점유율을 차지했으며, 또한 이 부문은 예측 기간 동안 시장에서 가장 높은 CAGR 4.9%를 기록할 것으로 예상됩니다.




유통 채널 기반 인사이트



의약품 중간체 시장은 유통 채널을 기준으로 유통과 직접 판매로 세분화되었습니다. 직접 판매 부문은 2020년 시장에서 가장 큰 점유율을 차지했으며, 유통 부문은 예측 기간 동안 시장에서 가장 높은 CAGR 4.2%를 기록할 것으로 추정됩니다.



전략적 통찰력



의약 중간체 시장에서 활동하는 회사는 제품 출시 및 확장과 같은 유기적 전략을 채택하여 전 세계적으로 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 해결하고 있습니다.



유형별



  • GMP

  • Non-GMP


응용 분야별





  • 항생제

  • 해열 진통제
  • 비타민

  • 기타


유통 채널별





  • 유통업체

  • 직판

  • li>

지역별





  • 북미


    • 미국

    • 캐나다

    • 멕시코



  • 유럽


    • 독일

    • 프랑스

    • 이탈리아

    • 영국

    • 스페인

    • 스위스

    • 벨기에

    • 그리스

    • 노르웨이

    • 포르투갈

    • 스웨덴

    • 체코

    • 크로아티아

    • 아일랜드

    • 덴마크

    • 네덜란드

    • 러시아< /li>
    • 기타 유럽



  • 아시아 태평양(APAC)


    • 중국

    • 인도

    • 대한민국

    • 일본

    • 호주

    • 기타 APAC



  • 중동 및 아프리카(MEA) )


    • 남아프리카

    • 사우디아라비아

    • UAE

    • 터키

    • 나머지 MEA


    • 중남미(SCAM)


      • 브라질

      • 아르헨티나

      • 나머지 SCAM


      < /li>

    회사 프로필





    • Pfizer, Inc

    • Dishman Group

    • Dextra Laboratories Limited

    • Sanofi Winthrop Industries SA

    • Vertellus Holdings LLC

    • BASF SE

    • Lianhetech

    • Codexis

    • Midas Pharma GmbH

    • Ciracon GmbH


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the Pharmaceutical Intermediates market across the globe?

Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.

What are Pharmaceutical Intermediates?

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.

What is the cost of Pharmaceutical Intermediates?

The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5–50, or more, per kgs. The cost may also differ from product to product types.

The List of Companies - Pharmaceutical Intermediate Market

  1. Pfizer Inc.
  2. Sanofi
  3. BASF SE
  4. Lianhe Chemical Technology Co., Ltd
  5. Dishman Carbogen Amcis Ltd
  6. Codexis
  7. Midas Pharma GmbH
  8. chiracon GmbH
  9. Dextra Laboratories Limited
  10. Vertellus Holdings LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports